Skip to content

Clinical trials

Myeloproliferative Disorders trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: Spain Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20132
20143
20151
20171
20182
20195
20204
20218
20221
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting9
Recruiting5
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation8
Novartis Pharmaceuticals6
Celgene3
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS3
AbbVie2
AOP Orphan Pharmaceuticals AG1
Ariad Pharmaceuticals1
Cogent Biosciences, Inc.1
Eli Lilly and Company1
Geron Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders32
Primary Myelofibrosis16
Hematologic Diseases9
Polycythemia Vera8
Bone Marrow Diseases7
Thrombocythemia, Essential6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive5
Leukemia, Myeloid, Acute5
Myelodysplastic Syndromes5
Leukemia4

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.